Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Eargo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Eargo şirketinin toplam hissedar öz sermayesi $45.1M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $69.8M ve $24.6M dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$46.02m
Eşitlik	US$45.13m
Toplam yükümlülükler	US$24.62m
Toplam varlıklar	US$69.75m

Son finansal sağlık güncellemeleri

Recent updates

Eargo: Straining To Be Heard

Aug 30

Eargo jumps 77% following FDA rule on OTC hearing aids

Aug 16

Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M

Aug 08

An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued

Jul 10

Eargo: I Am Slowly Starting To Listen

May 06

What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?

Jan 16

Eargo trades high afte hours on strong Q4 revenue, gross systems shipped

Jan 11

Eargo: A Word Of Caution

Dec 15

Eargo beats on revenue

Nov 19

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: EAR 'nin kısa vadeli varlıkları ( $56.7M ) kısa vadeli yükümlülüklerini ( $17.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: EAR şirketinin kısa vadeli varlıkları ( $56.7M ) uzun vadeli yükümlülüklerini ( $7.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: EAR borçsuzdur.

Borcun Azaltılması: EAR şirketinin 5 yıl önce borç/öz sermaye oranı 24.1% iken borcu yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: EAR şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: EAR un, serbest nakit akışı her yıl % 29.3 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Eargo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Eargo Files Form 15

Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency Is Cured

Nasdaq Grants 180 Calendar Days to Eargo, Inc. to Regain Compliance

Eargo Receives Non-Compliance Notice From Nasdaq

Eargo Receives a Non-Compliance Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC

Eargo Receives a Letter from the Nasdaq Stock Market

Recent updates

Eargo Files Form 15

Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index

Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings

Eargo, Inc. Announces Chief Financial Officer Changes, Effective from January 5, 2024

Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. (NasdaqGS:EAR) for $13 million.

Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. (NasdaqGS:EAR) for $13 million.

Eargo, Inc. to Report Q1, 2023 Results on May 11, 2023

Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency Is Cured

Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES

Nasdaq Grants 180 Calendar Days to Eargo, Inc. to Regain Compliance

Less than half of directors are independent

Eargo, Inc. Announces Board Changes

Eargo, Inc. Announces the Appointment of Donald Spence to Its Board of Directors

Eargo, Inc. has completed a Follow-on Equity Offering in the amount of $187.5 million.

Independent Director exercised options to buy US$273k worth of stock.

Eargo Receives Non-Compliance Notice From Nasdaq

Eargo Receives a Non-Compliance Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC

Price target decreased to US$2.00

Third quarter 2022 earnings released: US$1.29 loss per share (vs US$2.02 loss in 3Q 2021)

Eargo, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Eargo: Straining To Be Heard

Eargo jumps 77% following FDA rule on OTC hearing aids

Price target decreased to US$2.00

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Eargo, Inc., Annual General Meeting, Oct 12, 2022

Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M

Eargo, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Eargo completes $100M senior secured convertible notes issuance

Eargo, Inc.(NasdaqGS:EAR) dropped from Russell 2000 Growth Index

Eargo Receives a Letter from the Nasdaq Stock Market

Eargo Announces Receipt of Nasdaq Non-Compliance Letter

Eargo, Inc. announced delayed 10-Q filing

Eargo, Inc. announced delayed annual 10-K filing

Eargo, Inc. Launches Eargo 6 with Sound Adjust for Effortless Hearing

Eargo: A Binary Play On Hearing Loss

Price target decreased to US$10.50

Eargo Receives Notice from Nasdaq Stating Non Compliance with Listing Rule 5250(C)(1)

Eargo Is A High Risk 'Option' With High Potential

Eargo, Inc. Withdraws Financial Guidance for the Fiscal Year Ending December 31, 2021

Independent Director notifies of intention to sell stock

Consensus forecasts updated

Second quarter 2021 earnings released: US$0.50 loss per share (vs US$24.11 loss in 2Q 2020)

Eargo, Inc. Provides Financial Guidance for the Year 2021

Independent Director Geoffrey Pardo has left the company

Eargo Launches Eargo 5 Hearing Aid with Sound Match™ Technology

An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued

Chief Financial Officer notifies of intention to sell stock

Eargo, Inc.(NasdaqGS:EAR) dropped from Russell 3000E Value Index

Independent Director Juliet Bakker has left the company

Consensus EPS estimates increase to -US$1.00

First quarter 2021 earnings released: US$3.56 loss per share (vs US$33.52 loss in 1Q 2020)

Eargo, Inc. Increases Earnings Guidance for Full Year 2021

Eargo: I Am Slowly Starting To Listen

Independent Director notifies of intention to sell stock

Full year 2020 earnings released: US$3.80 loss per share (vs US$57.82 loss in FY 2019)

Analysts update estimates

Revenue and earnings beat expectations

Full year 2020 earnings released: US$3.80 loss per share (vs US$57.82 loss in FY 2019)

Analysts update estimates

Eargo, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: US$70.31

New 90-day high: US$63.00

What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?

Eargo trades high afte hours on strong Q4 revenue, gross systems shipped

Eargo: A Word Of Caution

Third quarter 2020 earnings released: US$24.38 loss per share

Eargo, Inc. Provides Earnings Guidance for the Full Year 2020

Eargo beats on revenue

Eargo, Inc. to Report Q3, 2020 Results on Nov 19, 2020